Medicine in the 21st Century
For the first time in history the diseases that come as a consequence of old age–such as cancer, heart attacks, stroke, and dementia–outweigh infectious disease as humankind's largest killers. Healthcare spendings for the population with an age of over 65 exceed 2 trillion USD in the US and Europe. The risk of getting any age-related disease increases exponentially around and after the age of 65. The risk for these kinds of diseases increases simultaneously, leading to the occurrence of multiple diseases of aging per individual, also referred to as multimorbidity. Thus, Apollo is not targeting single diseases but the root causes of aging to increase health span and the quality of life.
Progress in Longevity Research
New insights into the basic biology of aging, the underlying cause of all of these conditions, are enabling the creation of new therapies to prevent and even reverse these agonising diseases, allowing people to live healthier and more productive lives.
Progress in catalysing Health-Tech Technologies
The life-science industry is on the verge of an inflection point since new technologies like machine learning, lab automation or gene editing technologies enabling innovative biotechs to pursue bigger opportunities than ever before.
Apollo Health Ventures Strategy
Apollo collaborates with scientists and entrepreneurs to combine the most innovative findings of ageing research with state of the art catalysing technologies. Furthermore, Apollo supports its portfolio companies with strategic advice, hiring, data driven indication selection, drug development plans, IP strategy, pharma collaborations and finding syndication partners in further fundraising rounds.